Home | | Pharmacology | Sulfasalazine

Chapter: Basic & Clinical Pharmacology : Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics,& Drugs Used in Gout

Sulfasalazine

Sulfasalazine, a synthetic DMARD, is metabolized to sulfapyri-dine and 5-aminosalicylic acid.

SULFASALAZINE

Mechanism of Action

Sulfasalazine, a synthetic DMARD, is metabolized to sulfapyri-dine and 5-aminosalicylic acid. The sulfapyridine is probably the active moiety when treating rheumatoid arthritis (unlike inflam-matory bowel disease). Some authorities believe that the parent compound, sulfasalazine, also has an effect. In treated arthritis patients, IgA and IgM rheumatoid factor produc-tion are decreased. Suppression of T-cell responses to concanavalin and inhibition of in vitro B-cell proliferation have also been docu-mented. In vitro, sulfasalazine or its metabolites inhibit the release of inflammatory cytokines, including those produced by mono-cytes or macrophages, eg, interleukins-1, -6, and -12, and TNF-α. These findings suggest a possible mechanism for the clinical efficacy of sulfasalazine in rheumatoid arthritis.

Pharmacokinetics

Only 10–20% of orally administered sulfasalazine is absorbed, although a fraction undergoes enterohepatic recirculation into the bowel where it is reduced by intestinal bacteria to liberate sulfapyridine and 5-aminosalicylic acid (see Figure 62–8). Sulfapyridine is well absorbed while 5-aminosalicylic acid remains unabsorbed. Some sulfasalazine is excreted unchanged in the urine whereas sulfapyridine is excreted after hepatic acetylation and hydroxylation. Sulfasalazine’s half-life is 6–17 hours.

Indications

Sulfasalazine is effective in rheumatoid arthritis and reduces radio-logic disease progression. It has also been used in juvenile chronic arthritis and in ankylosing spondylitis and its associated uveitis. The usual regimen is 2–3 g/d.

Adverse Effects

Approximately 30% of patients using sulfasalazine discontinue the drug because of toxicity. Common adverse effects include nausea, vomiting, headache, and rash. Hemolytic anemia and methemo-globinemia also occur, but rarely. Neutropenia occurs in 1–5% of patients, while thrombocytopenia is very rare. Pulmonary toxicity and positive double-stranded DNA (dsDNA) are occasionally seen, but drug-induced lupus is rare. Reversible infertility occurs in men, but sulfasalazine does not affect fertility in women. The drug does not appear to be teratogenic.


Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Basic & Clinical Pharmacology : Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics,& Drugs Used in Gout : Sulfasalazine |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.